Spence

[Science in Vancouver @ScienceVancity]

Dr. Seyed Amirhossein Nasseri and tge Withers' lab (@withlabb) at @UBC are making waves with their latest publication! 🌊

Their work on identifying an alternative pathway for glycan degradation is featured on the latest @ImmunoPodcast episode!

🎧: https://t.co/GgGRitMB11

[Rhea Bains @rheabains]

Super proud of my labmate Amir (not on twitter), and others for publishing this beautiful story in Nature! It's been so great seeing this project evolve over the years! Highly recommend reading this one! @withlabb @BrumerLab @ubcmsl @ubcchem #glycotime

https://t.co/hWJ1FcucEi

[Eric Topol @EricTopol]

How a gut bacteria could make blood of all types universal, radically changing transfusion medicine
https://t.co/vh63tFzH2R
https://t.co/F5lZXwrrhw
@NatureMicrobiol

[Spence @spencemacdon]

@NJ_Spencer My money’s on zig

[Spence @spencemacdon]

@TheRog590 @24carm The Jays only need to be better than one of TEX or SEA, not both. TEX or SEA, will lose at least 4 games in the 7 TEXvSEA games, right? That is worst case for Jays. Even worse is if that team that lost 4 wins out, right? In that case the team will finish 6 and 4 = 90 wins

[Spence @spencemacdon]

@TheRog590 @24carm SEA and TEX both have 84 wins. One of those teams will lose 4 of 7. Assuming that team sweeps the other 3 games they will finish, best case, 6 and 4. 84+6=90. What am I missing?

[Spence @spencemacdon]

@TheRog590 @24carm I’m pretty sure 91 wins will do it. Best case for one of SEA and TEX is they can win a max of 90. Magic number is 6.

[Life Sciences BC @lifesciences_bc]

Member Spotlight: @AvivoBio (formerly ABOzymes), a British Columbia-based preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. https://t.co/SSdgIdeJtb

[GenomeBC @GenomeBC]

Here’s a scary-good story: we’re funding an @AvivoBio project that is testing an innovative technology to convert A blood types to O – paving the way to universal blood and organ transplants. If successful, this would be a life-saving leap forward.

Have a🩸good #Halloween.

[Avivo Biomedical Inc. @AvivoBio]

ABOzymes is now Avivo! Avivo means “from life and for life”. This name update reflects the evolution of the company, while maintaining our founding vision. Visit our new website: https://t.co/1HhlFavdR2 and be sure to play the video on the homepage.

[RSC Carbohydrate Group @CarbGroupUK]

A huge congratulations to our 2022 Haworth recipient, Prof Steve Withers (1/2)
https://t.co/rPpDMmzcU5

[Michael Smith Labs @ubcmsl]

🥳 Congratulations to Drs Stephen Withers (@withlabb), Peter Rahfeld @PRahfeld and collaborators on their successful seed funding to support their groundbreaking inroads with blood type antigen conversion at @ABOzymes. 🩸 👏

@CBR_UBC
#Glycomics
#BloodTransfusion
#health

[GlycoNet @glyconet_nce]

After more than two years of limited in-person opportunities for knowledge sharing and networking, GlycoNet was proud to host the 2022 Canadian Glycomics Symposium. Read some highlights from the event: https://t.co/OyMXRjgI60
#glycotime #glycomics

[Techcouver @techcouver]

ABOzymes Raises Seed Round To Fund Tech For Universal Blood Tranfusions ⁦@ABOzymes⁩ #bctech https://t.co/zeFPVIuSCE

[Joint Genome Institute @jgi]

Read in @ACSCentSci how ID'ing a novel glycoside phosphorylase enzyme led to the discovery of acholetin, from team incl. @spencemacdon @withlabb @ubcscience, @YasuoYoshikuni @jgi, @jbei @LBNLBioSci @advlightsource @BerkeleyLab. #synbio https://t.co/Qq6uA6uF4E

[Joint Genome Institute @jgi]

ICYMI in @ACSCentSci: Novel biopolymer produced by bacterial enzyme is biodegradable and may be biocompatible. From team incl. @spencemacdon @withlabb @ubcscience, @YasuoYoshikuni @jgi, @jbei @LBNLBioSci @advlightsource @BerkeleyLab. @doescience #synbio https://t.co/WYUk7b4eOL

[AdvancedLightSource @advlightsource]

Researchers discovered an enzyme that synthesizes a biopolymer similar to chitin, but linked in a different way. The polymer is biodegradable and may be biocompatible, with potential applications ranging from medical therapeutics to plastic alternatives. https://t.co/jfxlWNHNyd

[Joel Beasley @moderncto_io]

Peter Rahfeld, Co-founder & CSO at @ABOzymes, talks about transforming blood types by altering the antigens in the blood.

Check out the full episode now! https://t.co/RNoFODzxQd

#cto #medtech #innovation

[LBNL BioSci @LBNLBioSci]

Researchers from @jgi and @jbei were part of a team that identified a bacterial enzyme that produces a novel biopolymer called acholetin, similar to the major component of insect exoskeletons
https://t.co/w6d1zwLGAu

[Spence @spencemacdon]

@Wilnerness The one and only Jose Ghost?! You don’t say..🤔